André Vertruyen

1.1k total citations
12 papers, 672 citations indexed

About

André Vertruyen is a scholar working on Epidemiology, Infectious Diseases and Dermatology. According to data from OpenAlex, André Vertruyen has authored 12 papers receiving a total of 672 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Epidemiology, 3 papers in Infectious Diseases and 3 papers in Dermatology. Recurrent topics in André Vertruyen's work include Influenza Virus Research Studies (6 papers), Respiratory viral infections research (4 papers) and Food Allergy and Anaphylaxis Research (3 papers). André Vertruyen is often cited by papers focused on Influenza Virus Research Studies (6 papers), Respiratory viral infections research (4 papers) and Food Allergy and Anaphylaxis Research (3 papers). André Vertruyen collaborates with scholars based in Belgium, Germany and Switzerland. André Vertruyen's co-authors include Shai Ashkenazi, Bruce D. Forrest, William C. Gruber, Jonathan R. Skinner, Susanna Esposito, Timo Klemola, Daniel Desgrandchamps, Sheau‐Mei Cheng, Javier Arı́stegui and Timo Vesikari and has published in prestigious journals such as PEDIATRICS, Vaccine and The Pediatric Infectious Disease Journal.

In The Last Decade

André Vertruyen

12 papers receiving 635 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
André Vertruyen Belgium	11	469	147	132	124	105	12	672
Ankie Lebon Netherlands	9	131 0.3×	157 1.1×	39 0.3×	54 0.4×	41 0.4×	12	365
Paul C. McNabb United States	7	245 0.5×	135 0.9×	11 0.1×	11 0.1×	25 0.2×	11	343
Lijoy Varghese Belgium	9	234 0.5×	28 0.2×	69 0.5×	20 0.2×	6 0.1×	19	297
Karsten Koetz Sweden	6	628 1.3×	407 2.8×	27 0.2×	75 0.6×	36 0.3×	7	812
Stephen J. Lerman United States	13	215 0.5×	103 0.7×	6 0.0×	4 0.0×	70 0.7×	26	379
M. Uhart France	12	326 0.7×	38 0.3×	28 0.2×	3 0.0×	13 0.1×	29	404
Sandra Jo Hammer United States	7	161 0.3×	78 0.5×	16 0.1×	12 0.1×	17 0.2×	8	285
S Chumdermpadetsuk Thailand	12	303 0.6×	141 1.0×	2 0.0×	16 0.1×	34 0.3×	23	441
Amit Bhavsar Belgium	9	303 0.6×	67 0.5×	63 0.5×	2 0.0×	37 0.4×	21	434
Steven J. Sperber United States	9	118 0.3×	53 0.4×	3 0.0×	13 0.1×	61 0.6×	16	266

Countries citing papers authored by André Vertruyen

Since Specialization

Citations

This map shows the geographic impact of André Vertruyen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by André Vertruyen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites André Vertruyen more than expected).

Fields of papers citing papers by André Vertruyen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by André Vertruyen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by André Vertruyen. The network helps show where André Vertruyen may publish in the future.

Co-authorship network of co-authors of André Vertruyen

This figure shows the co-authorship network connecting the top 25 collaborators of André Vertruyen. A scholar is included among the top collaborators of André Vertruyen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with André Vertruyen. André Vertruyen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

Vesikari, Timo, Thomas Becker, André Vertruyen, et al.. (2016). A Phase III Randomized, Double-blind, Clinical Trial of an Investigational Hexavalent Vaccine Given at Two, Three, Four and Twelve Months. The Pediatric Infectious Disease Journal. 36(2). 209–215. 22 indexed citations

Sigurgeirsson, Bárður, Andrzej Boznański, Gail Todd, et al.. (2015). Safety and Efficacy of Pimecrolimus in Atopic Dermatitis: A 5-Year Randomized Trial. PEDIATRICS. 135(4). 597–606. 101 indexed citations

Herck, Koen Van, Ilse De Coster, André Vertruyen, et al.. (2014). Long-term Antibody Persistence in Children After Vaccination With the Pediatric Formulation of an Aluminum-free Virosomal Hepatitis A Vaccine. The Pediatric Infectious Disease Journal. 34(4). e85–e91. 12 indexed citations

Zedda, Luisanna, Eduardo Forleo‐Neto, André Vertruyen, et al.. (2014). Dissecting the Immune Response to MF59-adjuvanted and Nonadjuvanted Seasonal Influenza Vaccines in Children Less Than Three Years of Age. The Pediatric Infectious Disease Journal. 34(1). 73–78. 30 indexed citations

Hatz, Christoph, Jakob P. Cramer, André Vertruyen, et al.. (2012). A randomised, single-blind, dose-range study to assess the immunogenicity and safety of a cell-culture-derived A/H1N1 influenza vaccine in adult and elderly populations. Vaccine. 30(32). 4820–4827. 20 indexed citations

Black, Steven, Giovanni Della Cioppa, Anne Malfroot, et al.. (2010). Safety of MF59-adjuvanted versus non-adjuvanted influenza vaccines in children and adolescents: An integrated analysis. Vaccine. 28(45). 7331–7336. 35 indexed citations

Ruer‐Mulard, M., Werner Aberer, Anthony Gunstone, et al.. (2009). Twice‐daily versus Once‐daily Applications of Pimecrolimus Cream 1% for the Prevention of Disease Relapse in Pediatric Patients with Atopic Dermatitis. Pediatric Dermatology. 26(5). 551–558. 32 indexed citations

Backer, Marc De, Marie‐Anne Morren, Hugo Boonen, et al.. (2008). Belgian Observational Drug Utilization Study of Pimecrolimus Cream 1% in Routine Daily Practice in Atopic Dermatitis. Dermatology. 217(2). 156–163. 7 indexed citations

Wielen, Marie Van der, et al.. (2007). Immunogenicity and Safety of a Pediatric Dose of a Virosome-Adjuvanted Hepatitis A Vaccine. The Pediatric Infectious Disease Journal. 26(8). 705–710. 26 indexed citations

10.

Vesikari, Timo, Douglas Fleming, Javier Arı́stegui, et al.. (2006). Safety, Efficacy, and Effectiveness of Cold-Adapted Influenza Vaccine-Trivalent Against Community-Acquired, Culture-Confirmed Influenza in Young Children Attending Day Care. PEDIATRICS. 118(6). 2298–2312. 127 indexed citations

11.

Ashkenazi, Shai, André Vertruyen, Susanna Esposito, et al.. (2006). Superior Relative Efficacy of Live Attenuated Influenza Vaccine Compared With Inactivated Influenza Vaccine in Young Children With Recurrent Respiratory Tract Infections. The Pediatric Infectious Disease Journal. 25(10). 870–879. 231 indexed citations

12.

Berg, Andrea von, Prakash Jeena, André Vertruyen, et al.. (2004). Efficacy and safety of ipratropium bromide plus fenoterol inhaled via Respimat® Soft Mist™ Inhaler vs. a conventional metered dose inhaler plus spacer in children with asthma. Pediatric Pulmonology. 37(3). 264–272. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact